Cargando…

Humanized microbiota mice as a model of recurrent Clostridium difficile disease

BACKGROUND: Clostridium difficile disease is the leading antibiotic-associated cause of diarrhea and nosocomial acquired infection in the western world. The per annum burden in the USA alone amounts to 250,000 cases with 14,000 ascribed deaths and medical costs in excess of a billion dollars. Novel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, James, Auchtung, Jennifer M., Schaefer, Laura, Eaton, Kathryn A., Britton, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546040/ https://www.ncbi.nlm.nih.gov/pubmed/26289776 http://dx.doi.org/10.1186/s40168-015-0097-2

Ejemplares similares

Dietary trehalose enhances virulence of epidemic Clostridium difficile
por: Collins, J., et al.
Publicado: (2018)

Microbiota in vitro modulated with polyphenols shows decreased colonization resistance against Clostridioides difficile but can neutralize cytotoxicity
por: Mahnic, Aleksander, et al.
Publicado: (2020)

Identification of Simplified Microbial Communities That Inhibit Clostridioides difficile Infection through Dilution/Extinction
por: Auchtung, Jennifer M., et al.
Publicado: (2020)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Recurrence of Clostridium difficile infection in the Western Australian population
por: Alfayyadh, M., et al.
Publicado: (2019)

A prediction model for Clostridium difficile recurrence
por: LaBarbera, Francis D., et al.
Publicado: (2015)

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection
por: Dupont, Hebert, et al.
Publicado: (2017)

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Song, Yang, et al.
Publicado: (2013)

Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022)

Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections
por: Wang, Tiffany, et al.
Publicado: (2018)

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection
por: Hecker, Michelle T., et al.
Publicado: (2016)

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018)

Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)

Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018)

Correction: Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Publicado: (2014)

Tea and Recurrent Clostridium difficile Infection
por: Oman Evans II, Martin, et al.
Publicado: (2016)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016)

Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
por: Carlucci, Christian, et al.
Publicado: (2016)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
por: Lin, Zayar, et al.
Publicado: (2020)

CRISPR Diversity and Microevolution in Clostridium difficile
por: Andersen, Joakim M., et al.
Publicado: (2016)

Cost Effectiveness Analysis of Fecal Transplant Delivery Methods for Recurrent Clostridium difficile Infections in Outpatients
por: Walker, Jeremey, et al.
Publicado: (2017)

Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection
por: Knafl, Daniela, et al.
Publicado: (2019)

Updates in Treatment of Recurrent Clostridium difficile Infection
por: Singh, Tanveer, et al.
Publicado: (2019)

Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
por: Vincent, Caroline, et al.
Publicado: (2015)

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)

Is a Single Fecal Microbiota Transplant a Promising Treatment for Recurrent Clostridium difficile Infection?
por: Hota, Susy S, et al.
Publicado: (2018)

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
por: Olmedo, Maria, et al.
Publicado: (2019)

Colonization Resistance of the Gut Microbiota against Clostridium difficile
por: Pérez-Cobas, Ana Elena, et al.
Publicado: (2015)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Epidemiology of Clostridium difficile infection in Asia
por: Collins, Deirdre A, et al.
Publicado: (2013)

Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection
por: Kim, Kyeong Ok, et al.
Publicado: (2019)

Microbiota Accessible Carbohydrates Suppress Clostridium difficile Infection in a Murine Model
por: Hryckowian, Andrew J, et al.
Publicado: (2018)

Treatment of recurrent Clostridium difficile colitis: a narrative review
por: Hopkins, Roy J, et al.
Publicado: (2018)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection
por: Smith, Ashley D., et al.
Publicado: (2019)

Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection
por: Karadsheh, Zeid, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6qlp7um5juoqpsuk5u4n0g96iv